Shu Zhang

机构：University of Hawaiʻi at Mānoa, University of Hawaii System, Nanjing Forestry University, University of California, San Francisco, Sichuan University, Cancer Center of Hawaii, Sichuan Cancer Hospital, University of Hawaii Cancer Center · ORCID：0009-0005-0368-9397

发表论文 115 篇 · 总被引 966 次 · h-index 13

代表论文

• Data from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025 · 被引 1)
• Supplementary Figure S5 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)
• Supplementary Figure S8 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)
• Supplementary Data S2 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)
• Supplementary Figure S9 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)
• Supplementary Data S6 from Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma (2025)